OpenVSafe by OpenVAERS
Search V-safe

WEY-19025-61329

4 vaccinations 2 coded responses 32 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
532 / WI
Registered
2021-01-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-23
    Registered in v-safe
  2. 2021-01-23
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-23
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-13
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-11-29
    Dose 3 — Pfizer-BioNTech
  21. 2022-02-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2022-05-30
    Survey response — 6 months, dose 3
    MedDRA: Laboratory test abnormal — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tested positive on 5/13.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-05-30
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  24. 2022-06-01
  25. 2022-11-28
    Dose 4 — Pfizer-BioNTech
  26. 2022-11-29
    Health check-in — 12 months, dose 3
    Feeling: Fair
    Adult check-in
  27. 2022-11-29
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  28. 2022-12-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  29. 2022-12-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  30. 2022-12-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  31. 2022-12-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · None
    Adult check-in
  32. 2022-12-05
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  33. 2022-12-12
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-12-19
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-12-28
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  36. 2023-01-02
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  37. 2023-01-11
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  38. 2023-02-28
    Survey response — 3 months, dose 4
    MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  39. 2023-02-28
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  40. 2023-03-01
  41. 2023-03-01
  42. 2023-05-29
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-23Pfizer-BioNTech
22021-02-13Pfizer-BioNTech
32021-11-29Pfizer-BioNTech No
42022-11-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-05-30 Unsuccessful
2023-02-28 Unsuccessful

Free text

Release 11 — 6 months, dose 3

2022-05-30

Symptoms: Tested positive on 5/13.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDLaboratory test abnormal · · ✓
SDNasopharyngitis · · ✓
SDSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…